David P. Wood
2023
Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
2023 • Andrew J. Armstrong, George J. Netto, Michelle A. Rudek, Susan Halabi, David P. Wood, Patricia Creel, Kelly Mundy, S. L. Davis, Ting Wang, Roula Al...
2023
Supplementary Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
2023 • Andrew J. Armstrong, George J. Netto, Michelle A. Rudek, Susan Halabi, David P. Wood, Patricia Creel, Kelly Mundy, S. L. Davis, Ting Wang, Roula Al...
2023
Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
2023 • Andrew J. Armstrong, George J. Netto, Michelle A. Rudek, Susan Halabi, David P. Wood, Patricia Creel, Kelly Mundy, S. L. Davis, Ting Wang, Roula Al...
2023
Supplementary Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
2023 • Andrew J. Armstrong, George J. Netto, Michelle A. Rudek, Susan Halabi, David P. Wood, Patricia Creel, Kelly Mundy, S. L. Davis, Ting Wang, Roula Al...
2024
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life
2024 • Sagar A. Patel, Dattatraya Patil, Joseph A. Smith, Christopher S. Saigal, Mark S. Litwin, Jim C. Hu, Matthew R. Cooperberg, Peter R. Carroll, Eric...
Open Author Page
Exploring foci of
2024-10-24
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life
2024-10-24 • Sagar A. Patel, Dattatraya Patil, Joseph A. Smith, Christopher S. Saigal, Mark S. Litwin, Jim C. Hu, Matthew R. Cooperberg, Peter R. Carroll, Eric...
Importance The association between radiotherapy (RT) timing after radical prostatectomy and long-term patient-reported health-related quality of life (HRQOL) in men with prostate cancer is unknown. Objective To measure long-term HRQOL in men with prostate cancer up to 15 years after prostatectomy with or without RT and examine whether early vs late postprostatectomy RT is associated with differences in sexual, urinary, and bowel HRQOL. Design, Setting, and Participants A prospective, multicenter, longitudinal coho…
Open Article Page
Timing Belt (Camshaft)
Variable Valve Timing
Ignition Timing
Timing Attack
Open Article Page
Exploring foci of
2023-03-31
Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
2023-03-31 • Andrew J. Armstrong, George J. Netto, Michelle A. Rudek, Susan Halabi, David P. Wood, Patricia Creel, Kelly Mundy, S. L. Davis, Ting Wang, Roula Al...
<div>Abstract<p><b>Purpose:</b> Given discrepancies between preclinical and clinical observations of mammalian target of rapamycin (mTOR) inhibition in prostate cancer, we sought to determine the pharmacodynamic effects of the mTOR/TORC1 inhibitor rapamycin in men with intermediate- to high-risk prostate cancer undergoing radical prostatectomy.</p><p><b>Experimental Design:</b> Rapamycin was given at 3 or 6 mg orally for 14 days before radical prostatectomy in men wi…
Open Article Page
Hello Muddah, Hello Fadduh (A Letter From Camp)
Computer Data Storage
So Far From God
Tales From Planet Earth
Tokenization (Data Security)
Plan 9 From Outer Space
Away From Her
The Girl From Everywhere
The View From Saturday
Open Article Page
Exploring foci of
2023-03-31
Supplementary Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
2023-03-31 • Andrew J. Armstrong, George J. Netto, Michelle A. Rudek, Susan Halabi, David P. Wood, Patricia Creel, Kelly Mundy, S. L. Davis, Ting Wang, Roula Al...
Supplementary Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
Open Article Page
Hello Muddah, Hello Fadduh (A Letter From Camp)
Computer Data Storage
So Far From God
Tales From Planet Earth
Tokenization (Data Security)
Plan 9 From Outer Space
Away From Her
The Girl From Everywhere
The View From Saturday
Open Article Page
Exploring foci of
2023-03-31
Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
2023-03-31 • Andrew J. Armstrong, George J. Netto, Michelle A. Rudek, Susan Halabi, David P. Wood, Patricia Creel, Kelly Mundy, S. L. Davis, Ting Wang, Roula Al...
<div>Abstract<p><b>Purpose:</b> Given discrepancies between preclinical and clinical observations of mammalian target of rapamycin (mTOR) inhibition in prostate cancer, we sought to determine the pharmacodynamic effects of the mTOR/TORC1 inhibitor rapamycin in men with intermediate- to high-risk prostate cancer undergoing radical prostatectomy.</p><p><b>Experimental Design:</b> Rapamycin was given at 3 or 6 mg orally for 14 days before radical prostatectomy in men wi…
Open Article Page
Hello Muddah, Hello Fadduh (A Letter From Camp)
Computer Data Storage
So Far From God
Tales From Planet Earth
Tokenization (Data Security)
Plan 9 From Outer Space
Away From Her
The Girl From Everywhere
The View From Saturday
Open Article Page
Exploring foci of
2023-03-31
Supplementary Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
2023-03-31 • Andrew J. Armstrong, George J. Netto, Michelle A. Rudek, Susan Halabi, David P. Wood, Patricia Creel, Kelly Mundy, S. L. Davis, Ting Wang, Roula Al...
Supplementary Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
Open Article Page
Hello Muddah, Hello Fadduh (A Letter From Camp)
Computer Data Storage
So Far From God
Tales From Planet Earth
Tokenization (Data Security)
Plan 9 From Outer Space
Away From Her
The Girl From Everywhere
The View From Saturday
Open Article Page